Synlab targets $6 billion market capitalization in Frankfurt IPO as COVID-19 testing booms

Synlab set the price range for its planned IPO in Frankfurt at €18 to €23 a share, giving the German laboratory services provider a market capitalization of up to $6 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.